Skip to content

Observational study of different treatment protocols for cerebral hemorrhage

A prospective observational study of the efficacy of different treatment regimens for cerebral hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092933
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-11-27
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral hemorrhage

Interventions

intracerebral hemorrhage patient group:None
Normal control:None

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient group: 1. Age 18-80 years old, gender is not limited; 2. Patients who are clinically diagnosed with intracerebral hemorrhage in the acute and subacute period (24 hours to 14 days after the onset of the disease); 3. CT confirmed intracerebral hemorrhage; 4. Good compliance, signed informed consent form by the person and/or legal guardian and able to accept follow-up at the specified time. Healthy test group: 1. The health examination population of the physical examination center in the same period that matches the age and gender of the patient.d time

Exclusion criteria

Exclusion criteria: Patient group: 1. Pregnant or lactating women; 2. Unable to complete the follow-up plan as required; 3. Patient or his/her legal guardian is unwilling to sign a written informed consent document. Healthy test group: 1. Previous or history of cerebral hemorrhage, cerebral ischemia or other central nervous system diseases; 2. Previous or history of psychiatric illness; 3. Pregnant or lactating women; 4. Unable to complete the follow-up plan as required; 5. Patient or his/her legal guardian is unwilling to sign a written informed consent form.

Design outcomes

Primary

MeasureTime frame
Barthel Index scale score;Death;The modified Rankin Scale (mRS) score;Transcranial Doppler ultrasound;Head CT examination;Head MRI examination;National Institutes of Health Stroke Scale (NIHSS) score;

Secondary

MeasureTime frame
Hamilton Anxiety Scale (HAMA) score;Hamilton Depression Scale (HAMD) score;Blood biochemical examination;Routine urine and stool examination;Routine electroencephalogram examination;Mini-Mental State Examination (MMSE) scale score;Montreal Cognitive Assessment (MoCA) scale score;

Countries

China

Contacts

Public ContactZhouping Tang

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

ddjtzp@163.com+86 139 7161 6328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026